Thursday, 08 July 2010 10:00

BASF Fine Chemicals Switzerland SA and BASF Orgamol Pharma Solutions SA merger announced

Written by
Rate this item
(0 votes)

2011 02 01 091658BASF has announced the merger of its Swiss group companies BASF Orgamol Pharma Solutions SA, Evionnaz, and BASF Fine Chemicals Switzerland SA, Evionnaz, to a single organization. The company arising from the merger is called BASF Pharma (Evionnaz) SA and is based in Evionnaz, Switzerland.

President of the new organization is Martin Widmann, General Manager of the former BASF Fine Chemicals Switzerland SA and head of the BASF Pharma Ingredients & Services Business Unit. "The merger reduces complexity at our site and simplifies processes," Widmann said. "The two companies have been working closely together with success for many years." Managing Director of BASF Pharma (Evionnaz) SA will be Dr. Folker Ruchatz, former head of BASF Orgamol Pharma Solutions SA.

BASF Orgamol Pharma Solutions SA in Evionnaz, Switzerland and its sister company, BASF Orgamol Pharma Solutions France SAS in Saint-Vulbas, France, were uniformly renamed "BASF Pharma" at the end of April 2010. "The renaming of both companies is part of our strategy of becoming more customer-centric as a supplier and partner to the pharmaceutical industry," Widmann stated. "It shows our clear commitment to the pharmaceutical industry and enhances our market visibility."

The merger has no effect on existing contracts with employees, suppliers and customers, which will be transferred unchanged to BASF Pharma (Evionnaz) SA. Nor will there be any change in the number of employees.

The Evionnaz site has a more than 50-year history of producing customized active substances and advanced intermediates exclusively and in complete confidence for pharmaceutical companies. The BASF experts provide services covering the entire pharmaceutical lifecycle, from kilogram-scale production to commercial manufacture and from early-stage clinical development to original product launch and subsequent generic drug status.

About BASF’s business unit Pharma Ingredients & Services

BASF produces and markets a broad range of active ingredients and excipients, as well as exclusive synthesis services for the pharmaceutical industry. These products are made using the latest technologies, to the highest quality standards and in compliance with cGMP guidelines. Further information can be found at www.pharma-ingredients.basf.com .

About BASF

BASF is the world’s leading chemical company: The Chemical Company. Its portfolio ranges from chemicals, plastics and performance products to agricultural products, fine chemicals and oil and gas. As a reliable partner BASF creates chemistry to help its customers in virtually all industries to be more successful. With its high-value products and intelligent solutions, BASF plays an important role in finding answers to global challenges such as climate protection, energy efficiency, nutrition and mobility. BASF posted sales of more than €50 billion in 2009 and had approximately 105,000 employees as of the end of the year. Further information on BASF is available on the Internet at www.basf.com.

Read 5003 times Last modified on Saturday, 16 July 2016 11:33